CIRCADIAN THERAPEUTICS
Circadian Therapeutics develops drugs that derive their therapeutic effects through modulation of the control of sleep and circadian rhythm. Circadian rhythms are essential for leading the human body through its daily cycle, governing a number of factors such as body temperature, cardiovascular efficiency, melatonin production, and, crucially, sleep. Circadian Therapeutics is aiming to replace hospital-based, expensive diagnostics through the development of a home-based ambulatory electroencephalogram (EEG) device that will provide accurate and minimally intrusive measurement of brain function and circadian rhythms.
CIRCADIAN THERAPEUTICS
Social Links:
Industry:
Medical Device Pharmaceutical Therapeutics
Founded:
2016-01-01
Address:
Oxford, Oxfordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.circadiantherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
+44 (0) 01865 3338 000
Email Addresses:
[email protected]
Total Funding:
2 M GBP
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API WordPress Mobile Non Scaleable Content Microsoft Exchange Online Office 365 Mail GoDaddy DNS
Current Employees Featured
Founder
Investors List
Oxford Science Enterprises
Oxford Science Enterprises investment in Venture Round - Circadian Therapeutics
Official Site Inspections
http://www.circadiantherapeutics.com
- Host name: 176.168.205.92.host.secureserver.net
- IP address: 92.205.168.176
- Location: Germany
- Latitude: 51.4476
- Longitude: 7.0122
- Timezone: Europe/Berlin
More informations about "Circadian Therapeutics"
About | Circadian Therapeutics
Founded in 2016 as a spin-out from Oxford University, our world-leading science is based on the understanding of the molecular control of circadian rhythms, enabling us to develop unique …See details»
Circadian Therapeutics - Crunchbase Company Profile …
Circadian Therapeutics develops drugs that derive their therapeutic effects through modulation of the control of sleep and circadian rhythm. Circadian rhythms are essential for leading the human body through its daily cycle, …See details»
Circadian Therapeutics - LinkedIn
Circadian Therapeutics was founded in September 2016 as a spin-out from Oxford University with the aim to deliver benefit and value for all its stakeholders; patients, healthcare providers and ...See details»
Circadian Therapeutics Company Profile | Management and
Www.circadiantherapeutics.com . Circadian Therapeutics Profile and History. Circadian Therapeutics was founded in September 2016 as a spin-out from Oxford University with the …See details»
Circadian Therapeutics - Company Profile & Staff Directory
Circadian Therapeutics was founded in September 2016 as a spin-out from Oxford University with the aim to deliver benefit and value for all its stakeholders; patients, healthcare providers and …See details»
Circadian Therapeutics Overview | SignalHire Company Profile
Circadian Therapeutics was founded in September 2016 as a spin-out from Oxford University with the aim to deliver benefit and value for all its stakeholders; patients, healthcare providers and …See details»
Sleep and circadian rhythm disruption addressed with …
19th December 2016. Circadian Therapeutics aims to develop therapeutics and diagnostics for modulation of the body's circadian rhythms. Circadian Therapeutics, a life sciences spinout of Oxford University, has been …See details»
Circadian Rhythms Disruption | Circadian Therapeutics
[email protected] +44 (0) 1865 338000. Registered Office. CIRCADIAN Therapeutics Limited Registered Office: Weston Library, Broad Street, Oxford OX1 3BG. …See details»
Overview, News & Similar companies - ZoomInfo.com
Who is Circadian Therapeutics. Circadian Therapeutics was founded in September 2016 as a spin-out from Oxford University with the aim to deliver benefit and value for all its sta …See details»
CIRCADIAN THERAPEUTICS LIMITED - Companies House
CIRCADIAN THERAPEUTICS LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, …See details»
Circadian Therapeutics - PitchBook
Dec 8, 2017 Information on valuation, funding, cap tables, investors, and executives for Circadian Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Circadian Therapeutics - VentureRadar
Develops treatments targeting diseases associated with circadian rhythm disruptions, including Parkinson's, Alzheimer's, and metabolic disorders, to improve health and well-being.See details»
Circadian Therapeutics - Oxford Science Enterprises
Latest News All Company News 14•12•21 Portfolio News Circadian Therapeutics announces the first subject recruited to Phase I study for CT-1500, marking move to a clinical stage company …See details»
Circadian Therapeutics - Craft
Circadian Therapeutics has 5 employees across 2 locations and $2.5 m in total funding,. See insights on Circadian Therapeutics including office locations, competitors, revenue, financials, …See details»
Circadian Therapeutics - Products, Competitors, Financials, …
Circadiantherapeutics.com. Overview & Products; Financials; People; Founded Year 2016. Stage Seed VC | Alive. Total Raised $2.48M. Last Raised $2.48M | 8 yrs ago. About Circadian …See details»
Circadian Therapeutics - Company Profile - Tracxn
Dec 9, 2024 Circadian Therapeutics - Developer of therapeutics to treat circadian rhythm disruption. Raised a total funding of $12M over 3 rounds from 2 investors. Valued at $7.38M. …See details»
Portfolio - Circadian Therapeutics
Contact. Oxford Centre for Innovation New Road Oxford OX1 1BY. [email protected] +44 (0) 1865 546581See details»
Circadian Rhythms | Circadian Therapeutics
Disruption to normal circadian rhythms can have many psychological and physiological impacts, both short and long-term. Acute short-term impacts include; impulsivity and loss of empathy, …See details»
Articles - Circadian Therapeutics
Apr 5, 2019 Circadian Therapeutics announces the first subject recruited to Phase I study for CT-1500, marks move to a clinical stage company • First subject dosed for Phase I study• CT …See details»